University of Rochester Wilmot Cancer Institute

Cancer Prevention and Control Faculty Positions

The Cancer Prevention and Control (CPC) Research Program within University of Rochester Wilmot Cancer Institute (WCI) invites candidates to apply for full-time tenure-track faculty positions (all ranks considered). 

Opportunity highlights:

• Opportunities for leadership responsibility within the Wilmot Cancer Institute and the URCC NCORP Research Base (as appropriate for experience). Interact with basic, translational, and clinical scientists across all research programs within the WCI.  Maintain an innovative, independent, collaborative and extramurally funded research program and participate fully in CPC Program meetings and activities. Work in partnership with more than 30 highly collaborative faculty and trainees conducting cancer prevention, cancer control and cancer care delivery research across 4 schools and 15 departments.  Access to all WCI shared resources including: 1) the biostatistics and bioinformatics resource, 2) the clinical trials office and infrastructure, 3) the genomics research center, 4) a tissue bio-specimen repository, 5) the human biophysiology resource for behavioral intervention design and delivery, physical activity and functional assessments, patient-reported outcome assessments, and molecular biological assessments, and 6) the Office of Community Outreach and Engagement

Cancer Prevention and Control Research Program

The CPC Research Program has been conducting cancer control and cancer care delivery research with continuous funding from the National Cancer Institute (NCI) for more than 40 years.  Under the direction of Drs. Mustian and Mohile, the investigators in this Program work towards a common vision to lower cancer morbidity and mortality through primary prevention and supportive care research. 

Members of the CPC program are internationally renowned for their landmark contributions to the field of oncology in specialty areas including: primary prevention, cancer control, supportive care, behavioral oncology, exercise oncology, geriatric oncology, survivorship, health disparities and training. 

Wilmot Cancer Institute

WCI is comprised of the James P. Wilmot Cancer Center—our flagship 86-bed, inpatient and outpatient facility located on the University of Rochester Academic Medical Center campus contiguous with Strong Memorial Hospital—and 11 additional outpatient locations covering a 27-county region surrounding Rochester.  WCI offers patients and their families comprehensive services including one of upstate New York’s largest blood and bone marrow transplant programs, one of the only ACOS-accredited Breast Cancer Centers, and the first clinical Survivorship and Integrative Oncology Programs. 

In addition to connection in a highly collaborative community of investigators, members of the CPC Program and WCI have access to four extremely valuable resources:

• University of Rochester Cancer Center NCI Community Oncology Research Program (URCC NCORP) Research Base (MPIs Mustian and Morrow):  WCI is home to one of only two NCI-funded NCORP Research Bases in the United States in an Academic Medical Center.  The URCC NCORP Research Base is a legacy Research base with a long and sustained track record of funding, success and growth; URCC is one of the original Research Bases that were funded within the NCI Community Clinical Oncology Program (CCOP) in 1983—the predecessor to today’s NCORP.  The URCC NCORP Research Base is a research hub for investigators where they can utilize a network of >25 NCI-funded community-based NCORP affiliates across the United States, which includes more than 700 geographically different community-based oncology practices and a highly efficient infrastructure for clinical trial recruitment across the U.S.  This resource provides unique sources of collegial support, scientific expertise, and infrastructure to aid with development of scientific ideas and grants, as well as the conduct of studies within the regional WCI catchment area and the national NCORP catchment area.  
• Center for Research on Flavored Tobacco Products (CRoFT; WCI MPIs Rahmen, Ossip and McIntosh): WCI is one of select few cancer centers in the U.S. with a Tobacco Center for Regulatory Research.  Our recently funded center is a collaborative center with Roswell Park Cancer Institute.  CRoFT foci include four main areas: 1) assessing flavor and toxicity, 2) characterizing flavors and their impact on behavior, 3) determining respiratory health effects of flavors, and 4) evaluating the effects of product marketing.  This center also provides CPC investigators with access to unique cores and pilot funding. 
• Clinical and Translational Cancer Control Research Training Program (CCRTP; MPIs Janelsins and Morrow):  The WCI CCRTP provides PhD and MD trainees with the tools and experiences necessary to establish careers as outstanding independent investigators in clinical and translational cancer control research.  Our trainees produced 145 unique manuscripts, obtained several prestigious research awards, and earned $4.1 million in research funding.  To date, 29 of the 31 trainees who completed the program (last 15 years) obtained tenure-track academic positions, and achieved a total of $63 million in independent funding, including 25 R-grants.  Throughout our history, we have recruited approximately 50% women and 30% minority trainees.  A majority (94%) of our trainees are still in academic cancer research-focused careers at Assistant (15), Associate (11), and Full (3) Professor levels; some have also become leaders or directors of major programs within cancer centers.
• Clinical and Translational Science Institute:  The University of Rochester Medical Center was one of the first 12 academic medical centers in the country to receive a Clinical and Translational Science Award (CTSA) 2006 and has been continuously funded since that time.  The initial $40 million grant allowed URMC to leverage additional funding and build the $60 million Saunders Research Building, which brings together clinical and translational scientists and resources (e.g., WCI CPC Program, URCC NCORP, others) under one roof.  CPC investigators have access to all of the CTSI infrastructure, services, spaces and pilot funding provided by the CTSI. 

Our Commitment to Diversity, Equity, and Inclusion:

The University of Rochester is committed to fostering, cultivating and preserving a culture of diversity and inclusion. The University believes that a diverse workforce and inclusive workplace culture enhances the performance of our organization and our ability to fulfill our important missions. The University is committed to fostering and supporting a workplace culture inclusive of people regardless of their race, ethnicity, national origin, gender, gender identity, sexual orientation, socio-economic status, marital status, age, physical abilities, political affiliation, religious beliefs, or any other non-merit fact, so that all employees feel included, equally valued and supported.

Requirements

Ph.D., MD, DO, or equivalent doctoral degree. Track record of independent funding at the R01 equivalent level (K99/R00 awardees also strongly considered).  Track record of scholarly production with recognizable and significant impact, and extramurally-funded research ideally from the National Cancer Institute, other NIH Centers or Institutes, the American Cancer Society, PCORI, or other equivalent support.  Research and expertise in primary prevention and/or cancer control/care delivery supportive care for patients, survivors, and caregivers (e.g., integrative oncology, nutrition, exercise oncology, geriatric oncology, health disparities). Investigators with experience in novel behavioral and lifestyle interventions for the primary prevention of cancer are strongly encouraged to apply. Investigators with research foci on the dissemination and implementation of novel and effective supportive care interventions into standard cancer care are also strongly encouraged to apply.  The referenced pay range represents the University’s good faith and reasonable estimate of the base range of compensation for this faculty position. Individual salaries will be determined within the job’s salary range and established based on (but not limited to) market data, experience, and expertise of the individual, and with consideration to related position salaries. Alignment of clinical incentive-based compensation may also be applicable and will be discussed during the hiring process. Faculty appointment will be in a department based on the training/expertise of the successful candidate.

The University of Rochester is responsive to the needs of dual career couples.

EOE Minorities/Females/Protected Veterans/Disabled

How to Apply:

A review of applications will begin on June 1, 2024, and continue until a highly qualified candidate is identified. All applicants must apply online. Please include cover letter, CV, research statement and contact info for 3 individuals who will provide letters of reference on your behalf when requested.